These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
644 related articles for article (PubMed ID: 35435938)
1. Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease. Young CB; Winer JR; Younes K; Cody KA; Betthauser TJ; Johnson SC; Schultz A; Sperling RA; Greicius MD; Cobos I; Poston KL; Mormino EC; JAMA Neurol; 2022 Jun; 79(6):592-603. PubMed ID: 35435938 [TBL] [Abstract][Full Text] [Related]
2. Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity. Costoya-Sánchez A; Moscoso A; Silva-Rodríguez J; Pontecorvo MJ; Devous MD; Aguiar P; Schöll M; Grothe MJ; JAMA Neurol; 2023 Oct; 80(10):1051-1061. PubMed ID: 37578787 [TBL] [Abstract][Full Text] [Related]
3. Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies. Sperling RA; Donohue MC; Rissman RA; Johnson KA; Rentz DM; Grill JD; Heidebrink JL; Jenkins C; Jimenez-Maggiora G; Langford O; Liu A; Raman R; Yaari R; Holdridge KC; Sims JR; Aisen PS J Prev Alzheimers Dis; 2024; 11(4):802-813. PubMed ID: 39044488 [TBL] [Abstract][Full Text] [Related]
4. Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment. Strikwerda-Brown C; Hobbs DA; Gonneaud J; St-Onge F; Binette AP; Ozlen H; Provost K; Soucy JP; Buckley RF; Benzinger TLS; Morris JC; Villemagne VL; Doré V; Sperling RA; Johnson KA; Rowe CC; Gordon BA; Poirier J; Breitner JCS; Villeneuve S; JAMA Neurol; 2022 Oct; 79(10):975-985. PubMed ID: 35907254 [TBL] [Abstract][Full Text] [Related]
5. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging. Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956 [TBL] [Abstract][Full Text] [Related]
6. Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study. Jack CR; Wiste HJ; Weigand SD; Therneau TM; Knopman DS; Lowe V; Vemuri P; Mielke MM; Roberts RO; Machulda MM; Senjem ML; Gunter JL; Rocca WA; Petersen RC Lancet Neurol; 2017 Jun; 16(6):435-444. PubMed ID: 28456479 [TBL] [Abstract][Full Text] [Related]
7. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease. Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558 [TBL] [Abstract][Full Text] [Related]
8. Associations Between Self and Study Partner Report of Cognitive Decline With Regional Tau in a Multicohort Study. Jadick MF; Robinson T; Farrell ME; Klinger H; Buckley RF; Marshall GA; Vannini P; Rentz DM; Johnson KA; Sperling RA; Amariglio RE Neurology; 2024 Jun; 102(12):e209447. PubMed ID: 38810211 [TBL] [Abstract][Full Text] [Related]